The shoe thing caught me completely off guard. Going up half a size felt like a vanity problem at first — until my heel pain, my ankle rolling on flat ground, and my tired feet by noon all started making sense as one connected story. Nobody had ever told me estrogen was holding my foot together.
Learn more about Rose →Estrogen receptors are present in fibroblasts — the cells responsible for producing and maintaining collagen throughout the body, including the dense network of ligaments that hold the foot's arch in place. When estrogen declines, collagen synthesis slows and degradation accelerates, leaving ligaments thinner, less tensile, and more prone to permanent elongation. This is not a gradual aging process that happens over decades; studies show measurable changes in ligament stiffness within the first few years of menopause transition.
The plantar calcaneonavicular ligament, commonly called the spring ligament, is the primary passive support for the medial longitudinal arch — the curve most people think of when they picture a foot arch. It works under enormous compressive and tensile load with every single step, and its integrity depends almost entirely on collagen quality. As estrogen-driven collagen degradation progresses, the spring ligament stretches and loses its recoil, allowing the arch to sag progressively and permanently under bodyweight.
Plantar fasciitis is frequently framed as a mechanical overuse injury, but the sharp uptick in cases among perimenopausal women points to a hormonal component that is increasingly well-documented. The plantar fascia is a thick band of collagen-dense connective tissue running along the sole of the foot; when collagen turnover is disrupted by estrogen loss, the fascia becomes less elastic and more vulnerable to microtearing under normal daily loads. This is why plantar fasciitis in midlife women often doesn't resolve with the rest and stretching protocols that work in younger patients.
Proprioception — the body's real-time sense of joint position and movement — relies partly on mechanoreceptors embedded in ligament tissue, and estrogen plays a role in maintaining those receptor populations and their sensitivity. As estrogen declines, proprioceptive accuracy in the ankle and foot decreases, meaning the neuromuscular system gets slower, less precise feedback about where the foot is in space. The practical result is increased ankle rolling, difficulty on uneven ground, and a compensatory walking pattern that places abnormal stress on the arch.
While ligaments provide passive arch support, the tibialis posterior tendon provides the dynamic, muscular support that actively lifts and maintains the arch during walking and standing. This tendon is one of the most collagen-dense structures in the lower leg, and tibialis posterior tendon dysfunction (TPFD) — a leading cause of acquired adult flatfoot — has a notably higher incidence in postmenopausal women. When both the passive ligament system and the active tendon are simultaneously weakened by collagen degradation, arch collapse can accelerate in a compounding cycle.
The subtalar joint sits just below the ankle and controls the side-to-side rocking motion of the heel — a movement called pronation and supination. Ligaments around this joint normally limit excessive inward rolling of the heel bone, but with estrogen-related laxity, those boundaries loosen. Chronic over-pronation at the subtalar joint is a known driver of arch flattening and cascades upward, contributing to knee, hip, and lower back pain in a chain of biomechanical consequences that often gets misattributed to aging rather than hormonal structural change.
Estrogen is a critical regulator of bone remodeling, and its decline accelerates resorption of bone throughout the skeleton — including the small bones of the foot. As the calcaneus (heel bone) and tarsal bones lose density, their structural geometry can subtly shift, altering the mechanical relationships between bones that the ligament system was calibrated to support. A foot that is changing shape at the bony level simultaneously with losing its ligament integrity is experiencing dual structural compromise that no amount of orthotics fully corrects without addressing the underlying hormonal picture.
Many women in perimenopause notice their shoe size increasing — a phenomenon that is often dismissed or attributed to weight gain, but which has a direct structural explanation. As arch height decreases and ligaments elongate, the foot literally spreads: it gets longer as the arch flattens and wider as the forefoot splays under redistributed load. Unlike shoe size changes from swelling or temporary weight fluctuation, arch-collapse-driven foot elongation involves permanent changes to ligament length and is not reversed by losing weight or reducing activity.
The small intrinsic muscles of the foot — the flexor digitorum brevis, the abductor hallucis, and several others — form a muscular floor that actively supports arch integrity under dynamic load, and their function depends on both adequate estrogen signaling and maintenance of muscle mass. Perimenopause and menopause accelerate sarcopenia (muscle loss) through multiple hormonal pathways, and the foot's intrinsic muscles are no exception; they atrophy and lose force output, removing the final muscular buffer against arch collapse. Targeted foot strengthening exercises can meaningfully slow this process, but they work best when started before significant atrophy has occurred.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.